Chemoinformaics analysis of 2-Methyl-6-methyleneocta-2,7-dien-4-ol
| Molecular Weight | 152.237 | nRot | 4 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 3 |
| Exact Molecular Weight | 152.12 | nRing | 0 |
| Solubility: LogS | -2.027 | nHRing | 0 |
| Solubility: LogP | 2.627 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.1707 |
| nHD | 1 | BPOL | 16.0513 |
| QED | 0.484 |
| Synth | 3.943 |
| Natural Product Likeliness | 2.917 |
| NR-PPAR-gamma | 0.201 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.007 |
| HIA | 0.013 |
| CACO-2 | -4.403 |
| MDCK | 0.0000296 |
| BBB | 0.815 |
| PPB | 0.697266 |
| VDSS | 1.787 |
| FU | 0.295448 |
| CYP1A2-inh | 0.236 |
| CYP1A2-sub | 0.107 |
| CYP2c19-inh | 0.052 |
| CYP2c19-sub | 0.85 |
| CYP2c9-inh | 0.02 |
| CYP2c9-sub | 0.728 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.412 |
| CYP3a4-inh | 0.009 |
| CYP3a4-sub | 0.317 |
| CL | 10.56 |
| T12 | 0.754 |
| hERG | 0.005 |
| Ames | 0.165 |
| ROA | 0.078 |
| SkinSen | 0.892 |
| Carcinogencity | 0.731 |
| EI | 0.939 |
| Respiratory | 0.954 |
| NR-Aromatase | 0.024 |
| Antiviral | No |
| Prediction | 0.945989 |